Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Discover the smartest strategies for using a rewards credit card. Learn how to maximize benefits and save on your expenses.
27,792 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
AI-driven demand and memory shortages could propel Micron to new highs by late 2027. This article lays out why a big ...
QuantumScape has fallen hard in early 2026. This guide walks you through what would move the stock higher, what could...
A sizable early-2026 investment in a gold-focused miner is turning heads. This article breaks down what it could mean...
Get ahead of ARBE's Q1 2026 results with a practical framework. This guide breaks down what to watch in arbe (arbe) 2...
Celebrity fashion moments can become financial talking points. This guide explains how to evaluate, insure, and sell ...
Frequency Electronics stock plummeting has traders watching closely. This guide breaks down the causes, what it means...
Oracle has shifted from a steady performer to a stock many traders watch for AI-driven momentum. This guide breaks do...
A fund exited its Centerra Gold stake after a 150% rally, triggering talks of profit-taking and risk management. This...
Solana is back in the spotlight as network upgrades and institutional interest pick up. The big question for investor...
U.S. regulators have cleared broader access to Anthropic’s Mythos model after a brief regulatory stand-off over safet...
Microsoft stock has fallen about 27% from its all-time high, but long‑term catalysts could help it double by 2030. Th...